Evidence-based·Updated November 20, 2026·How we grade evidence

5-Amino-1MQ

OtherNNMT inhibitor (research compound)

5-amino-1MQ has been studied only in cells and mice, almost entirely by the group that developed it and its company. In obese mice given injections under the skin, it caused about 5% weight loss over 11 days and limited fat gain over about 4 weeks without changing food intake; in old mice it improved muscle repair and grip strength. It has never been given to people in a published study, so there are no human benefits, safety data or doses. Only 3.5% of an oral dose was absorbed in mice. It is not FDA-approved.

Taking 5-Amino-1MQ with other supplements or medications?Check your whole list for interactions. Free, no account.

Research compound: not an approved drug or dietary supplement

This compound is sold for research and is not FDA-approved for human use or as a dietary supplement. Human evidence is limited; purity and dosing of consumer products are unverified. The data below is an evidence review for education only. Talk to a clinician before considering it.

Quick decision guide

May help most

No approved or proven use; laboratory research only

Common dosing range

No approved or established dose for people. Mouse studies injected about 10 to 34 mg per kg a day under the skin

When to expect effects

Not established in people

Watch out for

Not FDA-approved and never tested in people, so its safety is unknown; poorly absorbed by mouth in mice; in a lab screen it also blocked MAO-A, the enzyme targeted by MAO-inhibitor medicines, with unknown meaning for people; online products are unverified

What is it

5-amino-1MQ (5-amino-1-methylquinolinium) is a lab-made research compound, not an approved drug or a dietary supplement: it is not FDA-approved for any use, and on November 19, 2026 we found no published study in people on PubMed and no registered trial on ClinicalTrials.gov. It was developed by researchers at the University of Texas Medical Branch in Galveston as a blocker (inhibitor) of nicotinamide N-methyltransferase (NNMT), an enzyme that is more active in the fat tissue of obese mice. The lead researcher founded Ridgeline Therapeutics, and the later mouse studies were written partly or wholly by the company's employees, as the papers declare. Products sold under this name for weight loss or muscle have not been reviewed by FDA for identity, purity, dose or safety.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

A registered clinical trial of an NNMT inhibitor opens and you qualify, under medical supervision (none was listed for 5-amino-1MQ on ClinicalTrials.gov on November 19, 2026)
You want to lose weight or keep muscle with age: talk to a doctor about approved weight-loss treatments and exercise programs that have been tested in people

Probably skip if…

You would be buying capsules, powders or injections online, including "research use only" products: their identity, purity and dose are unverified, and the compound has never been tested in people
You expect the mouse weight-loss or muscle results to apply to you: no human study exists
You take antidepressants or other medicines that act on serotonin or similar brain chemicals: in a lab test it blocked MAO-A, and no one has studied what this means in people
You are pregnant, breastfeeding or planning a pregnancy: there are no data

Evidence at a glance

body weight and fat in obese mice

Mixed Evidence
Effect
About 5% weight loss in 11 days and less fat gain than untreated mice
Best fit
None in people
Time
Days to 4 weeks in mice

muscle repair and strength in old mice

Mixed Evidence
Effect
About 70% higher muscle torque after injury and about 40% higher grip strength than untreated old mice
Best fit
None in people
Time
1 to 8 weeks in mice

Evidence for 2 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

body weight and fat in obese mice

Mechanism only
Mixed Evidence

In mice made obese on a high-fat diet, injections of 5-amino-1MQ under the skin three times a day for 11 days caused a weight loss of about 5.1% from baseline, while untreated mice gained about 1.4%; fat pad mass and fat cell size fell (fat cells more than 30% smaller) and total cholesterol was about 30% lower, with no change in food intake. In a second study run by the developers' company, Ridgeline Therapeutics, about 4 weeks of once-daily injections at the higher dose (32 mg per kg) held fat gain to 1.3 g, compared with 4.7 g in untreated mice, and improved glucose tolerance, insulin levels and fatty liver changes. A third study found that combining it with a switch to a lean diet normalized body composition faster than the diet alone. These are mouse results and have never been tested in people. The lead researcher founded Ridgeline Therapeutics and other authors were its employees.

Effect size
About 5% weight loss in 11 days and less fat gain than untreated mice
Time to effect
Days to 4 weeks in mice
Best fit
None in people
Less likely
People seeking weight loss, who have not been studied

Bottom line: Injected 5-amino-1MQ reduced weight and fat in obese mice, but it has never been tested in people.

muscle repair and strength in old mice

Mechanism only
Mixed Evidence

In 24-month-old mice with an injected muscle injury, twice-daily injections of 5-amino-1MQ (5 or 10 mg per kg) increased muscle stem cell activity, produced muscle fibers nearly twice as large in cross-section, and raised the peak torque (a measure of muscle strength) of the injured muscle by about 70% compared with untreated mice. In mice treated from 22 to 24 months of age, daily injections gave about 40% greater grip strength than untreated sedentary mice, compared with about 20% from exercise alone and about 60% when both were combined. These are mouse results from the developers' group and company, and they have not been tested in older people.

Effect size
About 70% higher muscle torque after injury and about 40% higher grip strength than untreated old mice
Time to effect
1 to 8 weeks in mice
Best fit
None in people
Less likely
Older adults with muscle loss, who need proven care such as exercise and nutrition support

Bottom line: Old mice given injections recovered muscle better, but this has never been tested in people.

How it works

NNMT attaches a methyl group to nicotinamide (a form of vitamin B3), using up S-adenosylmethionine (SAM) and producing 1-methylnicotinamide (1-MNA). In cultured fat cells, 5-amino-1MQ lowered 1-MNA, raised NAD+ and SAM, and reduced fat production; in lab tests it did not block related methyltransferase enzymes or enzymes of the NAD+ recycling pathway. The developers propose that more NAD+ and SAM in fat and muscle cells explains its effects. In a broad lab screening panel, a 10 micromolar concentration also blocked 67.4% of the activity of human monoamine oxidase A (MAO-A), the enzyme blocked by MAO-inhibitor medicines; the authors suggest this might add to its effect on blood sugar. In mice, only 3.5% of a dose given by mouth reached the bloodstream, which the developers attribute to limited absorption from the gut and fast breakdown in the liver; injections under the skin gave high blood levels and reached fat, muscle and liver. How much reaches the blood in people, by any route, is unknown.

How to take it

1. Typical dose
There is no approved or established dose for people, and no dose has ever been tested in people. In mouse studies, researchers injected it under the skin: 20 mg per kg three times a day (about 34 mg per kg a day of the compound) for 11 days in obese mice, 10 or 32 mg per kg once a day for about 4 weeks in obese mice, and 5 or 10 mg per kg twice a day, or 10 mg per kg once a day, in old mice. These are animal research doses, not recommendations, and they do not translate into a human dose.
2. Higher studied dose
No human dose has been studied. In a small dose-finding test in 2 obese mice, up to 150 mg per kg a day was given and 60 mg per kg a day was reported as well tolerated.
3. Timing
Not established.
4. With food
Not established. In mice, only 3.5% of a dose given by mouth reached the bloodstream.
5. Split dosing
Not established.
6. How long to try
Mouse studies lasted 11 days to 8 weeks. There are no human data of any duration.

What to track

If you have used it: tell your doctor and pharmacist, and bring the product
Any new or unusual symptom: get medical care and say what you took
Injection-site redness, swelling, warmth or pus, which can signal infection from a non-sterile product

Bottom line: No human dose exists, and nothing sold under this name has been tested in people.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Unknown: 5-amino-1MQ has never been given to people in a published study, so no side-effect profile existsIn obese mice, the developers reported no observable adverse effects at the doses studied and no change in food intake (an animal finding, not a human safety result)

Serious risks

  • No human safety data. We found no published human study and no registered trial on November 19, 2026. The published work consists of cell and mouse studies, mostly by the developers and their company; long-term safety, effects on the liver, kidneys, heart, pregnancy and cancer risk in people are unknown.

  • Off-target enzyme effect. In a lab screening panel, 5-amino-1MQ at 10 micromolar blocked 67.4% of the activity of human MAO-A, the enzyme blocked by MAO-inhibitor medicines. Whether this happens in people at any dose, and whether it causes interactions with medicines or foods, has not been studied.

  • Poor absorption by mouth and unverified products. In mice, only 3.5% of an oral dose reached the bloodstream, and the reported effects came from injections under the skin. Products sold under this name have no FDA review of identity, purity, dose or sterility.

Who should avoid it

Pregnancy & breastfeeding

There are no human data on 5-amino-1MQ in pregnancy, breastfeeding or fertility, and we found no pregnancy studies in animals. Avoid use if you are pregnant, breastfeeding or planning a pregnancy, and talk to your doctor.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

There is no FDA-approved 5-amino-1MQ product, so no label can show FDA approval
Labels saying "for research use only" or "not for human consumption" mean the product was not made or tested for people
The legitimate way to receive an experimental compound like this is a registered clinical trial listed on ClinicalTrials.gov; none was listed for 5-amino-1MQ on November 19, 2026

Be skeptical of…

"Clinically proven fat loss" or "melts fat without diet or exercise": shown only in mice given injections
"A natural alternative to GLP-1 drugs": it is a lab-made compound, and it has never been compared with any approved weight-loss medicine
"Builds muscle" or "reverses muscle aging": tested only in old mice
"Boosts NAD+ like NMN": raised NAD+ was measured in cultured fat cells, not in people
Oral capsules that "work like the studies": in mice only 3.5% of an oral dose was absorbed, and the reported effects came from injections
"Safe" or "no side effects": it has never been tested in people, and it blocked MAO-A in a lab screen

Frequently asked questions

Is 5-amino-1MQ FDA-approved?⌄

No. 5-amino-1MQ is an experimental lab compound developed as a possible drug. It is not approved by FDA for any use, and it has not completed any of the safety testing an approved medicine goes through.

Has 5-amino-1MQ been tested in people?⌄

No. On November 19, 2026 we found no published human study on PubMed and no registered trial on ClinicalTrials.gov. All published results come from cells and mice, mostly from the researchers who developed it and their company.

Does 5-amino-1MQ cause weight loss?⌄

In obese mice given injections under the skin, it caused about 5% weight loss over 11 days and limited fat gain over about 4 weeks, without changing how much they ate. No one knows whether it does anything in people, at what dose, or with what risks.

How does it compare with semaglutide or other weight-loss medicines?⌄

There is no comparison. Approved weight-loss medicines were tested in large human trials, while 5-amino-1MQ has only been tested in mice. It works on a different target (the NNMT enzyme in fat and muscle cells) and has never been studied against any approved medicine.

Do 5-amino-1MQ capsules work by mouth?⌄

That is unknown in people. In mice, only 3.5% of a dose given by mouth reached the bloodstream, and the reported weight and muscle effects came from injections under the skin.

Can I take 5-amino-1MQ with my supplements or medicines?⌄

No interaction studies exist. In a lab test it also blocked MAO-A, the enzyme targeted by MAO-inhibitor medicines, and no one has studied what that means in people. Ask a doctor or pharmacist to review your full list, especially if you take antidepressants, and tell them if you have used it.

References by claim

body weight and fat in obese mice

Neelakantan et al., 2018 · PMC (2018) link

Babula et al., 2024 · PMC (2024) link

Sampson et al., 2021 · PMC (2021) link

muscle repair and strength in old mice

Neelakantan et al., 2019 · PMC (2019) link

Dimet-Wiley et al., 2024 · PMC (2024) link

Safety

ClinicalTrials.gov search for 5-amino-1MQ (no registered studies, checked November 19, 2026) · ClinicalTrials.gov link

Track 5-Amino-1MQ with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 20, 2026·Evidence current as of Nov 20, 2026·How we grade evidence

Disclaimer: This compound is not approved by the FDA for human use and is not a dietary supplement. This page is an educational review of available research (much of it preclinical or early-stage), not a recommendation to use it. Consumer product quality is unregulated. Consult a qualified clinician.